The Saudi Food and Drug Authority (SFDA) has participated in the World Health Organization (WHO) advisory meeting held in Riyadh, attended by representatives from member states and several experts in the field of complementary and alternative medicine. The discussion focused on the WHO's 10-year strategy for complementary and alternative medicine (2025-2034). The meeting addressed technical opinions and proposals submitted by member states. A representative from the SFDA presented suggestions related to the strategy, particularly concerning legislation and regulation of herbal products. Moreover, the meeting agenda items were discussed, which included various proposals submitted by representatives of member states in preparation for their approval at the upcoming meeting scheduled for 2025. Source: Saudi Press Agency
Saudi Food and Drug Authority Participates in WHO Advisory Meeting
Recent Posts
Syrian Finance Minister Seeks Enhanced Economic Ties with UAE
September 28, 2026
UAE Initiates Third National Risk Assessment to Combat Financial Crimes
September 28, 2026
UAE and France Explore Cooperation on Asset Recovery at UN Congress
September 28, 2026
MBRSG Hosts Conference on Finance and International Trade Amid Protectionism
September 28, 2026